Worldwide Clinical Trials
Sara Davis has a extensive work experience in the clinical research industry. Sara currently holds the position of Chief Commercial Officer (CCO) at Worldwide Clinical Trials since May 2021. Prior to that, they served as the Executive Vice President, Global Commercial at the same company from June 2018 to May 2021. Before joining Worldwide Clinical Trials, Sara worked as the Executive Vice President, Global Business Development at Chiltern (acquired Theorem) from September 2015 to November 2017. Sara also served as the Senior Vice President Global Business Development at Theorem Clinical Research from November 2012 to 2015. Earlier in their career, Sara held various leadership roles at PRA International and i3 Research, focusing on business development. Sara was the Vice President Business Development at PRA International from 2008 to October 2012 and the Director of Business Development at the same company from 2000 to 2004. Sara also worked as the Executive Director Business Development at i3 Research from January 2004 to October 2008. Overall, Sara has a wealth of experience in global commercial and business development roles in the clinical research industry.
Sara Davis has a Master of Science degree in Psychology from California State University, Fullerton, where they graduated top of their class. Sara also has a Bachelor of Science degree in Business/Psychology from the University of Wisconsin Oshkosh. In addition, they have a certification in "Communicating about Culturally Sensitive Issues" from LinkedIn.
This person is not in any offices
Worldwide Clinical Trials
10 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.